Utility and efficacy of fluticasone propionate and salmeterol inhaled from a single inhaler for persistent asthma

Journal of Asthma

Volumn 42, Issue 10, 2005, Pages 829-831

  Mathison, David A ^a   Koziol, James A ^b  

^a SCRIPPS CLINIC   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Asthma; Fluticasone; Outcomes; Pharmacotherapy; Salmeterol

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COURSE EVALUATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG SUBSTITUTION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METERED DOSE INHALER; SAMPLE SIZE; SEVERE PERSISTENT ASTHMA; SPIROMETRY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; MIDDLE AGED; SPIROMETRY; TREATMENT OUTCOME;

EID: 30344453915     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900500369884     Document Type: Article

References (9)

1. Nelson HS, Chapman KR, Pyke SD, et al. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol 2003; 112:29-36.
2. Mathison DA, Koziol JA. Persistent asthma: Patient characteristics, courses of asthma, and utility of salmeterol. J Asthma 2000; 37:441-450.
3. Mathison DA, Koziol JA. Marginal utility of montelukast for persistent asthma. Chest 2002; 121:334-337.
4. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337:1405-1411.
5. Shapiro G, Lumry W, Wolfe J, et al. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med 2000; 161:527-534.
6. Matz J, Emmett A, Rickard K, et al. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations. J Allergy Clin Immunol 2001; 107:783-789.
7. Nguyen WT, Stewart C, Fisher K, et al. Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: Effect on outcomes in inner-city children enrolled in TennCare. Allergy Asthma Proc 2005; 26:129-134.
8. Xolair (Omalizumab) for Subcutaneous Use. Product Information. Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4990 (June 2003).
9. Holgate ST, Chuchalint AG, Hebert J, et al. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy 2004; 34:632-638.